Loading
Latest filing published 05 Mar 2026 for AEON Biopharma, Inc.. Read the official filing
No signal scores available.
All filings by Jennifer Sy on record concern AEON Biopharma, Inc. The record holds 2 filings, for trades running from 31 August 2024 to 17 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 5 March 2026, the filings show a share grant in AEON Biopharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations